Thought Leadership

Filter By Category

Adult Social Care
Covid
Dental
Diagnostics
E-Health
Fertility
Healthcare
Hospital - Acute
Hospital - Speciality
Hospitals & Clinics
Labs
Medical Devices
Multiple Sector Outlook
Pharma & Life Sciences
Primary Care
Social Care
Specialist Care

NHS Dental Contract Reform And Clawback Risk – How Far Away And How Real ?

In this article we examine areas of interest for investors – including the implications of a ne...

UK Elective Care: £10bn Boost For Independent Sector Providers

In this piece, we consider how understanding local demand and distinct commissioning arrangements...

Domiciliary Care: Quality Levels Sustained Despite Sector Pressures

In this article, we explore messages relevant to the domiciliary care sector, and look at what CQ...

Hospital Financial Strategies to Survive, and Then Thrive

In order for strong financial recovery to occur, it needs to begin now, even as we are still in t...

Europe’s Elective Surgery Backlog – A Boom for Private Clinics?

Europe’s predominantly public funded health systems have been struggling for many years to meet...

Life Sciences Investment in the Era of COVID-19 Part 3 of 3: Corporate M&A

The COVID-19 pandemic has reshaped each stage of the life science development and investment proc...

Marwood Thought Leadership Hightlights

As the leading healthcare advisory firm, Marwood has broad capabilities and an unmatched depth of...

Telehealth Takes Positive Steps Forward: What's Next?

In the President’s Executive Order Improving Rural and Telehealth Access, released August 3, al...

UK Specialist Healthcare: A Growing Market for Healthcare at Home

With the likelihood of activity in the market increasing towards the end of 2020, with investor a...

The Evolving Landscape of Prescription Digital Therapeutics for Mental Health in COVID-19 Era

Prescription digital therapeutics (PDTx) is an emerging category of evidence-based treatment gain...

Life Sciences Investment in the Era of COVID-19 Part 2 of 3: Public Equity

The COVID-19 pandemic has reshaped each stage of the life science development and investment proc...

Homecare in the Uk: Understanding Quality Challenges in a Growth Market

In this briefing note, we look at the fast-growing homecare sector, and the key regulatory questi...

Life Sciences Investment in the Era of COVID-19 Part 1 of 3: Venture Capital & Private Equity

While the life sciences industry has demonstrated its resilience in prior recessionary periods, t...

Payor Contracting Strategies and the Impact of Surprise Billing

The focus of federal policy makers on "surprise billing" has acted as a catalyst to change the co...

Basing Physician Compensation on wRVUs Aligns Incentives of All Stakeholders

Marwood believes a physician-led and productivity-based compensation plan allows for optimal subs...